WE ARE ON A MISSION
TO SAVE LIVES.
Kamada Plasma Specializes in Collecting Plasma
for the Production of Critical Therapies
Driving Innovation in the Plasma Industry
As one of the select plasma collection companies in the U.S., our centers are overseen by expert teams utilizing automated plasma collection machines. Our operations are FDA licensed and certified by the PPTA (Plasma Protein Therapeutics Association) and CLIA (Clinical Laboratory Improvement Amendments).
Specializing in Life-Saving Medications
Our focus is on collecting plasma to develop critical medications for rare and chronic diseases. As part of our services, we provide specialty plasma donation programs for products like Anti (D) immunoglobulin to prevent Hemolytic Disease of the Newborn and Rabies immunoglobulin for suspected rabies exposures. Additionally, we collect specialty plasma from rare donors for the manufacturing of blood typing reagents, diagnostic test kits, and research purposes.
Leveraging Global Experience and Expertise
Kamada Plasma is a wholly owned subsidiary of Kamada Ltd., a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. With a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities, we capitalize on the global expertise and strength of our parent company and plan to enhance our collection capabilities by investing in our current centers and to establish additional facilities across the U.S.
